STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

Introduction Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sharon L Naismith, Mark Woodward, Ruth Peters, Xia Wang, Craig S Anderson, Sophia Zoungas, Cheryl Carcel, Paula Muñoz-Venturelli, Karin Leder, Ian H Harding, Meng Law, Julian Elliott, Owen Hutchings, Carlos Delfino, Xiaolei Lin, Nirupama Wijesuriya, Ximena Stecher
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2025-04-01
סדרה:	BMJ Open
גישה מקוונת:	https://bmjopen.bmj.com/content/15/4/e089382.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!